Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 3, Issue 12, pp. 1344-1355
PubMed
Published By
Print ISSN
Online ISSN
History
- Received April 10, 2015
- Revision received June 9, 2015
- Accepted July 1, 2015
- Published first August 7, 2015.
Article Versions
- Previous version (August 7, 2015 - 05:33).
- Previous version (September 4, 2015 - 06:20).
- You are viewing the most recent version of this article.
Copyright & Usage
©2015 American Association for Cancer Research.
Author Information
- Daniela S. Thommen1,2,*,
- Jens Schreiner2,
- Philipp Müller2,
- Petra Herzig2,
- Andreas Roller3,
- Anton Belousov3,
- Pablo Umana4,
- Pavel Pisa4,
- Christian Klein4,
- Marina Bacac4,
- Ozana S. Fischer5,
- Wolfgang Moersig5,
- Spasenija Savic Prince6,
- Victor Levitsky4,
- Vaios Karanikas4,
- Didier Lardinois5, and
- Alfred Zippelius1,2,*
- 1Department of Medical Oncology, University Hospital Basel, Basel, Switzerland.
- 2Laboratory of Cancer Immunology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.
- 3Roche Pharma Research and Early Development, Roche Innovation Center Penzberg, Penzberg, Germany.
- 4Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.
- 5Department of Surgery, University Hospital Basel, Basel, Switzerland.
- 6Institute of Pathology, University Hospital Basel, Basel, Switzerland.
- ↵*Corresponding Authors:
Alfred Zippelius and Daniela S. Thommen, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland. Phone: 41-61-328-6016; Fax: 41-61-265-5316; E-mail: alfred.zippelius{at}usb.ch; and daniela.thommen{at}usb.ch
December 2015
Volume 3, Issue 12
Volume 3, Issue 12
Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors
Jump to section
Advertisement